Avtar Dhillon, MD
Executive Chairman at Emerald Health Therapeutics

Dr. Dhillon is a life sciences entrepreneur with more than 20 years’ experience building public companies through mergers and acquisitions, leading innovation in scientific, engineering and farming enterprises, securing government grants and NGO funding, and building dominant IP portfolios. As the founder/co-founder of seven life science companies, he raised over $500M in public and private and was awarded over $75M in government grants and contracts since 2001. During his tenure as President and CEO at Inovio Pharmaceuticals, Inc. (NASDAQ: INO), Dr. Dhillon successfully led the turnaround of the company through restructuring and the acquisition of technology from several European and North American companies. He led multiple successful financings, raising more than $300 million for the company, and concluded several licensing deals with global pharma leaders Merck, Wyeth (now Pfizer) and Roche. Before joining Inovio, he was Vice President of MDS Capital Corp. (now Lumira Capital Corp.), one of North American’s leading healthcare venture capital organizations. Currently, Dr. Dhillon serves as an active board member and chairman for a number of life science and investment companies, including Board Chair of the Cannabis Canada Council. Prior to his success as an entrepreneur and life-sciences CEO & Chairman, Dr. Dhillon practiced family medicine for over 12 years. He has a BSc (Honours) in Human Physiology, and an MD from the University of British Columbia.